5 best EDC platforms for dermatology clinical trials in 2026

A single inconsistent Psoriasis Area and Severity Index (PASI) score across two site visits can undermine a dermatology trial's primary endpoint, and rescoring after the fact rarely holds up to sponsor or regulatory scrutiny. Viedoc's EDC software builds automated calculation fields, standardized visit workflows, and image upload directly into the electronic case report form (eCRF), so raters enter consistent, audit-ready data at the point of care across 8,000-plus completed studies in 75-plus countries. This comparison reviews five EDC platforms for dermatology clinical trials across scoring consistency, photographic documentation, patient retention, and compliance.

You're running visits months apart with different raters, tracking lesion photographs against strict positioning and lighting protocols, and trying to keep participants engaged through a treatment course that can stretch well past a year. Standardized scoring only works if every rater enters data the same way, and photographic evidence only holds up if it's captured, stored, and linked to the right visit without manual reconciliation. A platform that can't enforce that consistency at the point of entry pushes the burden onto site staff and monitors instead.

Enterprise platforms built for large Phase III programs bring configuration cycles that can run close to Medidata's roughly 90-day build standard, timelines that don't suit a sponsor amending a scoring instrument mid-study. Commodity tools rarely offer the calculation logic or image handling a regulated dermatology trial needs. The platforms below are judged on scoring consistency, photography handling, and retention over long treatment courses.

Best EDC platforms for dermatology clinical trials: quick comparison

These five eClinical platforms represent the most evaluated options for dermatology clinical trials, reviewed across scoring consistency, photographic documentation, patient retention, and compliance.

1. Viedoc

Viedoc's EDC software lets your data managers build calculation fields for composite severity scores directly into the eCRF, reducing the manual scoring errors that can compromise a primary endpoint. Drag-and-drop workflows adapt to the multi-visit schedules typical of dermatology programs, and studies go live in as little as 8 weeks, with self-service builds ready in a day. That speed matters when a scoring instrument or photography protocol changes mid-study.

That same no-code Designer lets your team update calculation fields and workflows in-house when a scoring instrument changes. Viedoc's ePRO software extends that consistency to participants, letting them log symptom diaries and lesion photos between visits, offsetting retention risk over treatment courses running past a year. Unlimited user seats and transparent, study-based licensing keep costs predictable as a portfolio scales.

Viedoc is ISO 27001 and SOC 2 certified and supports FDA 21 CFR Part 11, ICH GCP, GDPR, EU Annex 11, and HIPAA, hosted on Microsoft Azure with 99.99% uptime. The platform has passed 100% of FDA inspections to date, backed by the Viedoc Inspection Readiness Packet (VIRP) available to every customer. Support runs 24/7 across global offices.

Data managers describe the same consistency at the build level. "Viedoc is a very user-friendly interface, easy to understand and navigate through. It offers customisable study workflow and tailoring it according to trial specification is easy." – Sanchita V., Data Manager.

Verified proof points:

• Study scale: 8,000+ studies run on Viedoc across 75+ countries
• Build speed: Study builds in as little as 8 weeks; self-service setups live in as little as one day
• Inspection readiness: 100% of FDA inspections passed to date; Viedoc Inspection Readiness Packet (VIRP) available to all customers
• Compliance: FDA 21 CFR Part 11, ICH GCP, GDPR, EU Annex 11, and HIPAA; ISO 27001 and SOC 2 certified
• Pricing: Unlimited user seats; no per-user fees; transparent, study-based licensing
• Support: 24/7 support across global offices

2. Medidata

Medidata offers Rave EDC, an electronic data capture system positioned as the cornerstone of the Medidata Clinical Cloud, a unified platform spanning study, patient, and data experiences. Rave EDC captures site-, patient-, and lab-reported data across Phase I to Phase IV trials and connects to adjacent Medidata applications including eConsent, electronic clinical outcome assessments (eCOA), randomization and trial supply management (RTSM), and medical imaging management, the last of which is relevant to programs that rely on standardized clinical photography. The platform supports protocol amendments and mid-study changes without system downtime, and Medidata reports Rave EDC has been used across more than 24,000 studies globally. Medidata is a Dassault Systèmes company headquartered in New York City, with a Rave Lite tier positioned for smaller or early-phase studies.

3. Veeva Vault EDC

Veeva EDC provides an end-to-end environment to collect, review, and process site-reported clinical trial data as part of the Veeva Clinical Platform, which unifies data collection with clinical trial management, trial master file, and outcomes assessment tools. Case report forms are configured through an in-product specification studio built on Agile Design principles, without custom programming, and the platform includes quality controls for querying, targeted source data verification, and protocol deviations. Protocol amendments apply to the database with no downtime, and the platform provides data lock and post-processing features, including end-of-study media creation, at study close. Veeva positions Vault EDC for life sciences organizations already using other Veeva Vault applications such as CTMS and eTMF.

4. Castor EDC

Castor EDC is a cloud-based electronic data capture and clinical data management system built around a low-code eCRF builder, aimed at biotech, MedTech, CRO, and academic research teams. Castor reports that it ranks among the top 5% of EDC providers for shortest build time, deploying low-complexity studies in as little as 3-4 weeks and reducing overall build times by up to 63%. The platform integrates data from electronic health records, case report forms, patient-reported outcome tools, laboratory systems, and wearable devices into a single environment, and supports FDA 21 CFR Part 11, ICH GCP, GDPR, HIPAA, ISO 27001, and ISO 9001 requirements. Founded in Amsterdam, Castor serves biotech, MedTech, CRO, and academic customers running interventional trials, patient registries, and post-market follow-up studies.

5. Medrio

Medrio provides a cloud-based electronic data capture and clinical data management system built for small and scaling clinical teams, with more than 20 years of use across early-phase through post-market studies. Studies are configured through a no-code, point-and-click builder with drag, drop, and copy functionality, and Medrio reports customers can go live within hours to days rather than weeks. An always-on testing environment lets teams validate form rules and mid-study changes before deployment, without data migration or extended system downtime. Medrio supports FDA 21 CFR Part 11, ICH E6(R2), HIPAA, and GDPR, and its suite extends to eCOA/ePRO, eConsent, RTSM, CTMS, and eTMF modules for teams that want a single vendor across the trial lifecycle.

What to look for in EDC platforms for dermatology clinical trials

Automated calculation for composite severity scores

Dermatology endpoints often rely on composite instruments such as the Psoriasis Area and Severity Index or the Eczema Area and Severity Index, combining several sub-scores into one value. If that calculation happens outside the eCRF, a transcription error can propagate straight into the primary endpoint. The evaluation criterion is whether the platform performs the calculation automatically, at the point of entry, rather than relying on the rater's arithmetic.

Best-in-class means configurable calculation fields built into the eCRF design, so a composite score updates automatically as sub-scores are entered and flags out-of-range values in real time. Look for a no-code designer that lets your own team adjust these fields when a protocol introduces a revised instrument. A platform that treats scoring as a manual step leaves your team reconciling errors months later, when a query is far costlier to resolve.

Clinical photography and image data handling

Many dermatology protocols require standardized photographs at every visit, captured under consistent lighting and positioning, then linked to the correct visit without a manual step. The evaluation question is whether the EDC can ingest and associate image data directly, or whether photography sits in a disconnected system that monitors have to reconcile by hand.

Best-in-class platforms support direct image upload within the eCRF or a validated API connection to a dedicated imaging system, keeping every photograph tied to its visit for central review. Open integration standards matter, since sponsors often already use a specialized photography vendor and need the EDC to connect to it rather than replace it.

Long-term patient retention and compliance tools

Dermatology treatment courses frequently run well past a year, and outcome compliance tends to drop as participants tire of visits and self-reported assessments. The evaluation criterion is whether the platform gives participants an easy way to stay engaged remotely, rather than relying on site visits alone.

Best-in-class support includes remote patient-reported outcome capture, automated reminders, and televisit options that reduce the burden of a long protocol on participants who might otherwise drop out. Without these tools, retention falls entirely on site coordinators, a harder job to scale across a multi-year program.

Mid-study amendment flexibility for evolving assessment instruments

Dermatology protocols amend more often than sponsors initially plan for, whether that's a revised scoring instrument or an added photography requirement partway through enrollment. The evaluation question is how much of that amendment your own team can execute directly, and how long the database is unavailable while it happens.

Best-in-class means a no-code designer your data managers use to update eCRFs and workflows in-house, tested in a staging environment before going live, with no downtime once deployed. Where amendments require a vendor programmer, expect the change to take weeks rather than days.

How to choose the right EDC platform for dermatology clinical trials

Step 1: Define how central subjective scoring is to your primary endpoint

Not every dermatology protocol lives or dies by a composite severity score, so start by mapping which endpoints depend on calculated, rater-entered values versus objective lab or imaging data. If your primary endpoint is a composite instrument, calculation automation and rater consistency tooling should weigh more heavily in your evaluation than general platform features. If your endpoints are mostly objective, you can prioritize other criteria instead.

Step 2: Assess how your program handles clinical photography today

Look at whether your current photography workflow already sits inside your EDC or is bolted on through a separate vendor and a manual transfer process. If it's separate, ask what it would take to bring image capture and storage into the eCRF itself, since that decision affects both monitor workload and how defensible your image data is under inspection.

Step 3: Evaluate your realistic mid-study amendment rate

Pull your last two or three dermatology protocols and count how many amendments touched the scoring instrument, visit schedule, or photography requirements. A program with frequent, moderate amendments needs in-house, no-code configuration far more than one with a stable, rarely changed design, and that difference should carry real weight in your platform choice.

Step 4: Scrutinize retention risk across your treatment duration

Map your typical treatment duration against your historical dropout curve, and identify where in that timeline participants tend to disengage. If retention risk clusters around long gaps between visits, weight remote patient-reported outcome and televisit capability more heavily than you would for a shorter, more frequent-visit protocol.

Step 5: Choose a platform built for the way your program actually runs

Weigh how each platform fits your scoring complexity, photography workflow, amendment cadence, and retention risk together, rather than optimizing for any single criterion in isolation. Viedoc's EDC software is built around this combination for dermatology programs, with in-house configuration, image capture, and ePRO-driven retention tools in one suite. If that matches your program, book a demo or request a proposal to see it against your own protocol.

Frequently asked questions

What is the best EDC software for dermatology clinical trials?

Viedoc's EDC software is the strongest fit for dermatology clinical trials, with automated calculation fields for composite severity scores, in-house image upload, and study builds in as little as 8 weeks so a revised scoring instrument doesn't stall enrollment. Medidata Rave EDC is the enterprise benchmark and connects to a dedicated medical imaging module, though its build and amendment cycles are generally longer and better suited to large, complex programs. Castor EDC offers a low-code alternative with fast, low-complexity builds for smaller dermatology programs.

What should you look for in an EDC platform for dermatology trials?

Prioritize whether the platform can automate calculations for composite severity scores such as the Psoriasis Area and Severity Index, since manual scoring is where transcription errors creep into a primary endpoint. Check how clinical photography is captured and linked to visits, whether that happens inside the eCRF or through a separate system that needs manual reconciliation. Look for remote patient-reported outcome and televisit capability to support retention across treatment courses that often run well past a year, and confirm how much of a mid-study scoring or protocol amendment your own team can execute without a vendor programmer. Validation depth and a complete audit trail matter throughout, since dermatology data is inherently more subjective and draws closer inspection scrutiny as a result.

How long does it take to build and deploy a dermatology study on a modern EDC platform?

It depends on study complexity and whether the build happens in-house or through professional services, but self-service teams configuring a straightforward dermatology protocol can have a database live in as little as one day. For studies built with professional services, expect roughly 8 to 12 weeks from signed work order to go-live, averaging around 10 weeks, with expedited timelines possible for less complex designs. The variable that matters most for dermatology specifically is how fast a mid-study amendment to a scoring instrument or photography requirement can be deployed once the protocol changes, since that happens more often than sponsors initially plan for.

How do EDC platforms support standardized severity scoring in dermatology trials?

A modern EDC supports standardized scoring by building the calculation logic for composite instruments directly into the eCRF, so a rater enters individual sub-scores and the platform calculates the composite value automatically rather than leaving that arithmetic to a spreadsheet or paper worksheet. Real-time edit checks flag out-of-range or inconsistent entries at the point of data entry, before they reach a query queue. The best platforms also let your own data management team configure or adjust these calculation fields in-house when a protocol introduces a revised or additional instrument, without waiting on a vendor change request.

Can an EDC platform manage clinical photography and image documentation for skin studies?

Yes, though the depth of that support varies by platform. Some EDC systems support direct image upload within the eCRF, tying each photograph to its visit and patient automatically, while others rely on an application programming interface (API) connection to a dedicated photography or imaging vendor. Either approach can work, but the evaluation question is whether images are reconciled to the right visit automatically or require a manual matching step that adds monitor workload and introduces risk of misattribution.

How does Viedoc's study build time compare to Medidata's?

Viedoc and Medidata Rave EDC take different approaches to study build. Viedoc is configured in-house through a no-code Designer, with go-live in as little as 8 weeks for managed builds and self-service setups live in as little as one day. Medidata Rave is generally configured by Medidata or its accredited implementation partners, an approach that suits large, complex programs but can extend build and amendment timelines compared with a self-service model. For a growth-stage sponsor amending a dermatology scoring instrument mid-study, the in-house build model usually wins on speed.

Making the right EDC choice for dermatology clinical trials

The five platforms reviewed here share real similarities: cloud-based capture, configurable eCRF design, and validated audit trails meeting the same core regulatory bar. Where they diverge is scope and weight, from enterprise suites built for large, multi-region programs to leaner platforms designed for growth-stage sponsors and mid-sized CROs. The global eClinical software market is estimated at over $11 billion in 2025, growing at roughly 14% annually, which keeps pushing vendors toward faster builds and more in-house configuration.

Matching platform to program comes down to a few variables: how central calculated scoring is to your endpoints, how your photography workflow is structured, how often protocols amend mid-study, and how long treatment runs. US-based teams typically weight build speed and return on investment most heavily, while EMEA and APAC teams tend to weight compliance credentials and vendor stability higher.

Switching an EDC platform mid-program carries real validation and retraining cost, and that cost compounds every time a scoring instrument changes without the flexibility to adapt in-house. Choosing a platform that fits your program's actual rhythm is usually cheaper across the life of a trial than the one that looked simplest at selection.

Why Viedoc is the best EDC choice for dermatology clinical trials

If standardized, defensible scoring sits at the center of your dermatology program, Viedoc's EDC software is built to keep it that way, with calculation fields for composite severity scores built into the eCRF and study builds in as little as 8 weeks from work order to go-live.

That same no-code Designer, plus unlimited user seats and transparent, study-based licensing, means your data management team can amend a scoring instrument or photography requirement mid-study without a vendor queue or unpredictable costs. Viedoc's ePRO software extends that same consistency to participants between visits, supporting retention across long treatment courses, backed by 24/7 customer success and certified Designer training.

Viedoc is ISO 27001 and SOC 2 certified, supports FDA 21 CFR Part 11, ICH GCP, GDPR, EU Annex 11, and HIPAA, and has passed 100% of FDA inspections to date, all backed by the Viedoc Inspection Readiness Packet available to every customer. The platform has run 8,000-plus studies across 75-plus countries since Viedoc's founding in 2003.

If you want an EDC platform built around how dermatology trials actually run, from subjective scoring to long-term retention, Viedoc is designed for exactly that. Book a demo or request a proposal and the team will walk through scoring automation, image handling, and inspection readiness against your own protocol.